A new investment fund structured by JPMorgan Chase…and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries. With $94 million committed by a pioneering group of investors…the Global Health Investment Fund…will help advance the most promising interventions to fight challenges in low-income countries such as malaria, tuberculosis, HIV/AIDS and maternal and infant mortality…[T]he Fund’s investor group includes…the International Finance Corporation, GlaxoSmithKline, Merck, The Pfizer Foundation, Storebrand and JPMorgan Chase...The GHIF will invest in new drugs and vaccines, emerging diagnostic tools, child-friendly formulations of existing products, expanding manufacturing capacity and other applications...[refers to GlaxoSmithKline, International Finance Corporation, JPMorgan Chase, LHGP Asset Management, Merck, Storebrand, Pfizer Foundation]